LawrenceDavidGinsbergMD

Psychiatry • Houston, TX

Lawrence D. Ginsberg , MD

Join to view full profile

Dr. Ginsberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ginsberg's full profile

Already have an account?

Office
17115 Red Oak Dr
Ste 109
Houston, TX 77090
Phone+1 281-893-4111

Fax+1 281-893-8082

Summary

Dr. Lawrence Ginsberg is a psychiatrist in Houston, TX. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 39 years. He is experienced in post-traumatic stress disorder, attention-deficit/hyperactivity disorder, bipolar disorders , depressive disorders, and autism spectrum disorders.

Education & Training

Baylor College of MedicineResidency, Psychiatry, 1982 - 1985
University of Miami/Jackson Health SystemInternship, Transitional Year, 1981 - 1982
University of Miami Leonard M. Miller School of MedicineClass of 1981

Certifications & Licensure

TX State Medical License 1985 - 2026

Clinical Trials

Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
Completed
Phase 2
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
Completed
Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders Start of enrollment: 2009 Feb 01
Completed
Phase 2
Biomarker and DNA Collection in Subjects Participating in Protocol 22003 Start of enrollment: 2009 May 01
Completed
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis Start of enrollment: 2009 Aug 01
Completed
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Start of enrollment: 2014 May 01
Terminated
Phase 2
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18
Completed
Phase 3
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder Start of enrollment: 2016 Oct 24
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

29 citations
The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.
Paul Herscu, Benjamin L. Handen, L. Eugene Arnold, Snape Michael Frederick, Joel D. Bregman
Journal of Autism and Developmental Disorders. 2020-09-01
9 citations
Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: ...
Richard H. Weisler, Lawrence Ginsberg, Bryan Dirks, Patrick Deas, Ben Adeyi
Journal of Attention Disorders. 2017-11-01
10 citations
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic o...
Robert L. Findling, Lawrence D. Ginsberg
Neuropsychiatric Disease and Treatment. 2014-08-27

Professional Memberships

American Society of Addiction Medicine - ASAM
Member